Penumbra Debt to Equity Ratio 2014-2019 | PEN
Current and historical debt to equity ratio values for Penumbra (PEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Penumbra debt/equity for the three months ending June 30, 2019 was 0.10.
| Penumbra Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-06-30 | $0.05B | $0.45B | 0.10 |
| 2019-03-31 | $0.05B | $0.44B | 0.11 |
| 2018-12-31 | $0.00B | $0.42B | 0.00 |
| 2018-09-30 | $0.00B | $0.41B | 0.00 |
| 2018-06-30 | $0.00B | $0.43B | 0.00 |
| 2018-03-31 | $0.00B | $0.42B | 0.00 |
| 2017-12-31 | $0.00B | $0.40B | 0.00 |
| 2017-09-30 | $0.00B | $0.38B | 0.00 |
| 2017-06-30 | $0.00B | $0.37B | 0.00 |
| 2017-03-31 | $0.00B | $0.37B | 0.00 |
| 2016-12-31 | $0.00B | $0.27B | 0.00 |
| 2016-09-30 | $0.00B | $0.25B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.24B | 0.00 |
| 2015-12-31 | $0.00B | $0.23B | 0.00 |
| 2015-09-30 | $0.00B | $0.23B | 0.00 |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.01B | $-0.01B | -0.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.167B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $107.920B | 22.99 |
| Intuitive Surgical (ISRG) | United States | $57.680B | 50.45 |
| Edwards Lifesciences (EW) | United States | $44.404B | 43.22 |
| IDEXX Laboratories (IDXX) | United States | $23.228B | 58.27 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $20.080B | 13.30 |
| Teleflex (TFX) | United States | $16.875B | 35.82 |
| Olympus (OCPNY) | Japan | $16.120B | 120.62 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.722B | 0.00 |
| DexCom (DXCM) | United States | $13.997B | 207.43 |
| Hologic (HOLX) | United States | $13.125B | 20.72 |
| STERIS (STE) | Ireland | $12.846B | 29.63 |
| Sysmex ADR (SSMXY) | Japan | $12.357B | 33.31 |
| Varian Medical Systems (VAR) | United States | $9.792B | 23.43 |
| ABIOMED (ABMD) | United States | $8.627B | 49.38 |
| Masimo (MASI) | United States | $7.861B | 47.70 |
| SARTORIUS AG (SARTF) | Germany | $6.158B | 54.71 |
| Integra LifeSciences Holdings (IART) | United States | $5.208B | 23.24 |
| Elekta AB (EKTAY) | Sweden | $4.982B | 39.76 |
| Globus Medical (GMED) | United States | $4.765B | 30.24 |
| LivaNova (LIVN) | United Kingdom | $3.768B | 28.73 |
| Cantel Medical (CMD) | United States | $3.704B | 37.58 |
| Tandem Diabetes Care (TNDM) | United States | $3.506B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.637B | 231.33 |
| Nihon Kohden (NHNKY) | Japan | $2.570B | 25.86 |
| Nevro (NVRO) | United States | $2.558B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.521B | 17.84 |
| Glaukos (GKOS) | United States | $2.203B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.710B | 31.72 |
| Silk Road Medical (SILK) | United States | $1.219B | 0.00 |
| Veracyte (VCYT) | United States | $1.198B | 0.00 |
| OPKO Health (OPK) | United States | $1.151B | 0.00 |
| Natus Medical (NTUS) | United States | $1.069B | 24.91 |
| Accelerate Diagnostics (AXDX) | United States | $1.005B | 0.00 |
| CryoLife (CRY) | United States | $0.976B | 93.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.954B | 29.96 |
| Inogen (INGN) | United States | $0.941B | 23.08 |
| Tactile Systems Technology (TCMD) | United States | $0.934B | 115.42 |
| Luminex (LMNX) | United States | $0.923B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.887B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.855B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.842B | 38.90 |
| AngioDynamics (ANGO) | United States | $0.697B | 22.81 |
| Quotient (QTNT) | Switzerland | $0.688B | 0.00 |
| AxoGen (AXGN) | United States | $0.583B | 0.00 |
| Intersect ENT (XENT) | United States | $0.505B | 0.00 |
| Si-Bone (SIBN) | United States | $0.453B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.442B | 0.00 |
| Fluidigm (FLDM) | United States | $0.440B | 0.00 |
| ViewRay (VRAY) | United States | $0.395B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.375B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.373B | 14.34 |
| Alphatec Holdings (ATEC) | United States | $0.355B | 0.00 |
| Sientra (SIEN) | United States | $0.322B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.312B | 52.75 |
| Accuray (ARAY) | United States | $0.295B | 0.00 |
| IRadimed (IRMD) | United States | $0.239B | 39.58 |
| CRH Medical (CRHM) | Canada | $0.235B | 81.50 |
| RTI Surgical (RTIX) | United States | $0.227B | 34.11 |
| TransEnterix (TRXC) | United States | $0.214B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.206B | 0.00 |
| Neuronetics (STIM) | United States | $0.179B | 0.00 |
| Stereotaxis (STXS) | United States | $0.167B | 0.00 |
| ConforMIS (CFMS) | United States | $0.126B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.099B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.069B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.063B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.059B | 0.00 |
| Vermillion (VRML) | United States | $0.053B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.052B | 0.00 |
| Electromed (ELMD) | United States | $0.044B | 22.61 |
| Xtant Medical Holdings (XTNT) | United States | $0.036B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.030B | 0.00 |
| Nuvectra (NVTR) | United States | $0.029B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.028B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.022B | 0.00 |
| Neovasc (NVCN) | Canada | $0.021B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.019B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 22.17 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Dynatronics (DYNT) | United States | $0.012B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.011B | 0.00 |
| Avinger (AVGR) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.005B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
